This is an observational study for people with certain solid tumors, including muscle invasive bladder cancer, esophageal cancer, gastric cancer, melanoma (skin cancer), and non-small cell lung cancer. The study aims to collect clinical information, blood, and tumor tissue samples to help develop better tests for understanding cancer, such as improving detection and predicting if cancer might return. You would receive your usual standard of care from your doctor. The main goal is to create a registry of these samples. This study is open to adults aged 18 and older who have stage I, II, or operable stage III cancer and are planning to have surgery. The study's status is currently unclear.

Study design

This is an observational study with a planned enrollment of 1350 participants. The phase of the study is not specified.

What's involved

You would provide blood and tissue samples as part of your routine standard of care. Your involvement is expected to last for approximately five and a half (5.5) years.

Compensation

Not stated in the trial record.

Follow-up

Participants will be observed from enrollment up to 5.5 years after enrollment to collect blood and tissue biospecimens.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.